All Products
Also known as
MUI, Mixed UI, Mixed urinary incontinence, Mixed incontinence, Combined stress and urge incontinence, Combined SUI and UUI
Definition
Mixed urinary incontinence (MUI) is a condition characterized by the involuntary leakage of urine that encompasses symptoms of both stress and urge incontinence simultaneously.1 Stress incontinence involves urine leakage triggered by physical exertion or increased intraabdominal pressure (e.g., coughing, sneezing, or exercising), while urge incontinence is marked by a sudden, intense need to urinate, followed by involuntary urine loss.2 The pathophysiology of MUI is complex, involving both pelvic floor weakness and detrusor muscle overactivity. The stress component primarily results from weakened pelvic floor muscles, prolapse, or loss of the normal urethrovesical angle, leading to inadequate urethral closure during physical exertion.3 The urge component stems from uninhibited bladder contractions caused by detrusor muscle overactivity, poor detrusor compliance, loss of neurologic control of bladder contractions, and bladder hypersensitivity.4 MUI is particularly prevalent in women older than 65, affecting more than 37% of older female patients, and often necessitates significant lifestyle changes due to its impact on both physical and psychosocial well-being.5
Clinical Context
Mixed incontinence is diagnosed and managed in clinical settings when patients present with symptoms of both stress and urge urinary incontinence.1 The initial assessment typically involves a detailed clinical history, physical examination, and simple office tests, including urinalysis, postvoid residual urine volume measurement, and pelvic examination.2 A 3-day bladder diary is recommended to objectively document voiding patterns, urgency episodes, and incontinence events.3 Treatment begins with conservative approaches, including lifestyle modifications (caffeine reduction, weight loss), pelvic floor muscle training (Kegel exercises), and bladder training.4 For patients with persistent symptoms, pharmacological treatments targeting the urge component (antimuscarinic medications) may be prescribed.5 In cases unresponsive to conservative therapies, surgical interventions may be considered, with emerging evidence suggesting that transobturator midurethral slings may be associated with lower rates of persistent urge symptoms compared to other procedures.2 The selection of treatment modalities is individualized based on symptom severity, the predominant component (stress or urge), patient preferences, and comorbidities.3 Effective management often requires a multidisciplinary approach involving urologists, urogynecologists, physical therapists, and primary care providers to address both the physical and psychosocial aspects of the condition.4